Michael Zinda, EVP, Chief Scientific Officer at Repare Therapeutics Inc. (RPTX), sold 15,677 shares at $12.03 ($189K) on 2023-06-07, disclosed to the SEC on 2023-06-09.
Scheduled sale ($189k) by EVP, Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.03 | 6,404 | $77K | 40.9% |
| 2 | $12.03 | 6,404 | $77K | 40.9% |
| 3 | $12.02 | 2,869 | $34K | 18.3% |
| Total | $12.03 avg | 15,677 | $189K | 100% |
| Filing → |
| RPTX | SELL | 2024-03-27 | $6K | — | Filing → |
| RPTX | SELL | 2023-06-07 | $14K | — | Filing → |
| RPTX | SELL | 2022-03-16 | $6K | — | Filing → |